United Therapeutics CorporationUTHRNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-35.0%
5Y CAGR-52.7%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-35.0%/yr
vs +4.5%/yr prior
5Y CAGR
-52.7%/yr
Recent acceleration
Acceleration
-39.5pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 13.96% |
| 2024 | 25.67% |
| 2023 | 31.66% |
| 2022 | 50.75% |
| 2021 | -9.01% |
| 2020 | 587.45% |
| 2019 | -117.65% |
| 2018 | 42.53% |
| 2017 | -41.68% |
| 2016 | 14.96% |